Finance

Beta
Lists
Q2 2026 earnings • released • EPS beat +3.54% • Revenue beat +4.90%
See results
VBNK:TSE
VersaBank
CA$26.71
-3.12%
(-0.86) 1D
Jun 4, 3:33:46 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for VBNK...
Open
CA$27.49
High
CA$27.60
Low
CA$24.89
Mkt. cap
887.64M
Avg. vol.
22.88K
Volume
43.79K
52-wk high
CA$28.80
52-wk low
CA$13.92
Beta
0.87
Shares outstanding
32.07M
No. of employees
131
Open
CA$27.49
High
CA$27.60
Low
CA$24.89
Mkt. cap
887.64M
Avg. vol.
22.88K
Volume
43.79K
52-wk high
CA$28.80
52-wk low
CA$13.92
Beta
0.87
Shares outstanding
32.07M
No. of employees
131
Analyst outlook
Analyst Ratings
Based on 2 analysts giving stock ratings to VBNK in the past 3 months
Buy
Buy
1
Hold
1
Sell
0
12 month forecast
Based on 2 Wall Street analysts offering 12 month price targets for VBNK in the last 3 months.
Highest
Current $26.71
$18.71 (-29.96%)
Average
$16.35 (-38.79%)
Lowest
$14.00 (-47.59%)
News stories
From sources across the web
Profile
VersaBank is a Canadian chartered bank headquartered in London, Ontario. Formerly known as the Pacific & Western Bank of Canada, it was founded as a trust company in Saskatoon, Saskatchewan, in 1980 and later moved its head offices to London, Ontario. On August 1, 2002, it was granted a Schedule I Canadian chartered bank licence by the Canadian federal government, the first in approximately 18 years. The bank is publicly traded as VBNK on both the Toronto Stock Exchange and on the Nasdaq. Wikipedia
About VersaBank
CEO-
Employees131
Founded1980
HeadquartersLondon, Ontario, Canada
SectorBank
Last report
Jun 3, 2026
Fiscal period
Q2 2026
EPS / Est. (CAD)
CA$0.39 / CA$0.38
+3.54%beat
Revenue / Est. (CAD)
38.29M / 36.50M
+4.90%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Apr 2025
Jul 2025
Oct 2025
Jan 2026
Revenue
29.25M
30.40M
33.77M
35.81M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
17.52M
21.65M
23.87M
20.55M
Operating expense
17.52M
21.65M
23.87M
20.55M
Total operating expenses
17.52M
21.65M
23.87M
20.55M
Operating income
11.73M
8.75M
9.90M
15.27M
Other non operating income
-
-
-
-
EBT including unusual items
11.73M
8.75M
9.90M
15.27M
EBT excluding unusual items
11.73M
8.75M
9.90M
15.27M
Income tax expense
3.20M
2.17M
4.70M
4.20M
Effective tax rate
27.31%
24.80%
47.44%
27.50%
Other operating expenses
-
-
-
-
Net income
8.53M
6.58M
5.20M
11.07M
Net profit margin
29.16%
21.65%
15.41%
30.91%
Earnings per share
-
0.30
0.33
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more